Provided by Tiger Trade Technology Pte. Ltd.

Organogenesis Holdings Inc

2.77
+0.00500.18%
Volume:110.79K
Turnover:306.08K
Market Cap:355.69M
PE:18.43
High:2.80
Open:2.78
Low:2.70
Close:2.76
52wk High:7.08
52wk Low:2.61
Shares:128.64M
Float Shares:57.95M
Volume Ratio:0.34
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1500
EPS(LYR):0.1500
ROE:9.04%
ROA:6.43%
PB:1.19
PE(LYR):18.43

Loading ...

Director Glenn H. Nussdorf Reports Disposal of Organogenesis Holdings Inc. Common Shares

Reuters
·
Dec 19, 2025

Organogenesis Plans to File Biologics Licenses Application for Knee Osteoarthritis Pain Therapy by 2025-End, Shares Up Pre-Bell

MT Newswires Live
·
Dec 16, 2025

Organogenesis Holdings Price Target Maintained With a $9.00/Share by BTIG

Dow Jones
·
Dec 16, 2025

Stocks to Watch: RCI Hospitality, Ready Capital, Organogenesis

Dow Jones
·
Dec 16, 2025

Organogenesis Confirmed to Start FDA License Application for ReNu

Dow Jones
·
Dec 16, 2025

Organogenesis to File BLA for ReNu After Positive FDA Meeting

Reuters
·
Dec 16, 2025

Organogenesis Holdings Inc - Submission Expected by End of 2025

THOMSON REUTERS
·
Dec 16, 2025

Organogenesis Announces Successful FDA Meeting and Plan to File Bla for Renu® for Knee Osteoarthritis Pain

THOMSON REUTERS
·
Dec 16, 2025

December 2025's Top Penny Stocks With Promising Potential

Simply Wall St.
·
Dec 16, 2025

Organogenesis Director and 10% Owner Glenn H. Nussdorf Reports Sale of Common Shares

Reuters
·
Nov 27, 2025

Organogenesis Holdings Is Maintained at Buy by BTIG

Dow Jones
·
Nov 20, 2025

Stock Track | Organogenesis Holdings Soars 22% on Stellar Q3 Earnings and Raised 2025 Outlook

Stock Track
·
Nov 07, 2025

Stock Track | Organogenesis Soars 10.54% After Hours on Strong Q3 Earnings and Raised 2025 Outlook

Stock Track
·
Nov 07, 2025

Regenerative medicine maker Organogenesis beats Q3 revenue estimates on rise in advanced wound care products

Reuters
·
Nov 07, 2025

Organogenesis Holdings Inc. reports third quarter net product revenue of $150.5 million

Reuters
·
Nov 07, 2025

Organogenesis Hldgs Q3 Adj. EPS $0.18 Beats $0.06 Estimate, Sales $150.587M Beat $134.100M Estimate

Benzinga
·
Nov 07, 2025

BRIEF-Organogenesis Q3 Net Product Revenue USD 150.5 Million

Reuters
·
Nov 07, 2025

Organogenesis Outlook FY Net Product Revenue USD 500-525 Million

THOMSON REUTERS
·
Nov 07, 2025

Organogenesis Holdings Inc expected to post earnings of 6 cents a share - Earnings Preview

Reuters
·
Nov 05, 2025

Director and 10% Owner Glenn H. Nussdorf Acquires Common Shares of Organogenesis Holdings Inc

Reuters
·
Nov 04, 2025